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ABSTRACT 
Lansoprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinerg ic or histamine 
H2-receptor antagonist properties, but rather suppress gastric acid secretion by specific inhibition of the (H+,K+)-ATPase enzyme system at the 
secretary surface of the gastric parietal cell. Because this enzyme system is regarded as the acid (proton) pump within the parietal cell, 
lansoprazole has been characterized as a gastric acid-pump inhibitor, in that it blocks the final step of acid production. This effect is dose-
related and leads to inhibition of both basal and stimulated gastric acid secretion irrespective of the stimulus. The aim of the present study was 
to develop lansoprazole loaded thiolated chitosan microspheres were prepared by emulsifying method using liquid paraffin light and heavy in 
ratio of 50:50 as a dispersing medium and glutaraldehyde used as a cross-linking agent. The prepared microspheres were evaluated for mean 
particle size and particle size distribution, drug content, mucoadhesion measurement and in-vitro drug release. FT-IR spectroscopic analysis 
was performed to ascertain drug polymer interaction. The release profiles showed first order release behavior up to 12 hours where the 
highest drug release was 88.89 % of the lansoprazole loaded in the thiolated chitosan microspheres, indicating a strong crosslinking between 
chitosan and glutaraldehyde. From the results of the present investigation it may be concluded that drug loaded chitosan microspheres can be 
prepared by a simple technique which avoids the use of complex apparatus and special precautions.  
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INTRODUCTION 
A drug delivery system is defined as a formulation or a 
device that enables the introduction of a therapeutic 
substance in the body and improves its efficacy and safety by 
controlling the rate, time and place of release of drugs in the 
body. The efficiency of any drug therapy can be described by 
providing a therapeutic amount of drug to the proper site of 
action to achieve the desired concentration of the drug in 
blood or tissues, for the desired therapeutic response which 
is therapeutically effective and non-toxic for a prolonged 
period of time1.  Recently the novel dosage forms which can 
control the release rate and target the active drug molecule 
to a particular site have attained a great formulation interest. 
Microspheres are one of the novel drug delivery system 
which possess several applications and are made up of 
assorted polymers2. Microspheres can be defined as solid, 
approximately spherical particles ranging in size from 1 to 
1000 μm range in diameter having a core of drug and 
entirely outer layers of polymers as coating material. They 
are made up of polymeric, waxy or other protective materials 
i.e. biodegradable synthetic polymer and modified natural 
products such as starches, gums, proteins, fats and waxes.  
However, the success of these microspheres is limited due to 
their short residence time at site of absorption3. The 
presence of polymers in sustained release drug delivery 
systems is important, because almost all of the system using 
the polymer as a carrier. Some time ago, polymers are 
divided into three major groups that are soluble polymers, 
biodegradable polymers or bioerodible, and mucoadhesive 
polymer4. Over time, the presence of polymers today are 
quite varied, even leading to multifunctional polymers, which 
can be as mucoadhesive, enzyme-inhibitor, permeation-
enhancers, and efflux pump-inhibitor5. One of the polymers 
included in the multifunctional polymer is chitosan. Chitosan 
has mucoadhesive properties, permeation-enhancers, and 
enzyme-inhibitor5. Chitosan obtained from chitin 
deacetylation resulting the free amino group that can make it 
be policationic6. Chitosan has been shown to have 
mucoadhesive properties due to electrostatic interactions 
between positively charged chitosan and negatively charged 
mucosal surface. Chitosan has one primary amino group and 
two free hydroxyl groups for each monomer. Free amino 
group in chitosan is positively charged subsequently react 
with the surface/mucus are negatively charged [7]. Various 
modifications have been made to the existing mucoadhesive 
polymer resulting in a better mucoadhesvie properties. One 
modification is done is with the immobilization of thiol 
groups to mucoadhesive polymer so as to form disulfide 
bonds with cysteine-rich subdomains of mucus 
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glycoproteins. Unlike the first generation mucoadhesive 
polymers attached to the mucus gel layer through 
noncovalent bonding, the new generation of mucoadhesive 
polymers capable of forming covalent bonds to the layer of 
mucus7. Modification of the thiol group attachment has also 
been made to the chitosan. This modification is based on the 
immobilization of thiol bearing movement on chitosan 
backbone, thus known as thiolated chitosan. This 
modification was developed to improve the solubility of 
chitosan, mucoadhesive property, and/or property of 
permeation8. Improved properties of mucoadhesive 
thiolated chitosan expected to increase the contact time of 
the drug in the gastrointestinal tract that it can increase the 
bioavailability of the drug. Lansoprazole chemical Name 2-
[(3-methyl-4-(2,2,2-trifluoroethoxy) pyridin-2-yl) 
methylsulfinyl]-1H-benzoimidazole, Molecular Weight: 
369.363 g/mol and half life 1.5hr. Lansoprazole belongs to a 
class of antisecretory compounds, the substituted 
benzimidazoles, that do not exhibit ant cholinergic or 
histamine H2-receptor antagonist properties, but rather 
suppress gastric acid secretion by specific inhibition of the 
(H+,K+)-ATPase enzyme system at the secretary surface of 
the gastric parietal cell9. Because this enzyme system is 
regarded as the acid (proton) pump within the parietal cell, 
lansoprazole has been characterized as a gastric acid-pump 
inhibitor, in that it blocks the final step of acid production. 
This effect is dose-related and leads to inhibition of both 
basal and stimulated gastric acid secretion irrespective of the 
stimulus. The stability of lansoprazole a proton pump 
inhibitor is a function of pH and it rapidly degrades in acidic 
medium of the stomach, but has acceptable stability in 
alkaline conditions10. To overcome inherent drawbacks 
associated with conventional dosage forms of lansoprazole, 
an attempt is being made to develop an alternative drug 
delivery system in the form of mucoadhesive microspheres. 
MATERIALS AND METHODS 
Materials 
Lansoprazole was obtained as a gift sample from Dr Reddys 
laboratories, Hyderabad. Thiolated Chitosan was acquired 
from Sigma-Aldrich (St. Louis, MO, USA). Tween-80 and 
span-80 from Qualigens, Mumbai. Glacial acetic acids were 
purchased from Merck Specialities pvt. Ltd., Mumbai, All 
other chemicals and reagent used were of analytical grade. 
Ultrapure water was used throughout the study. 
Preparation of thiolated chitosan microsphere 
Thiolated chitosan was selected for preparing microsphere. 
Microspheres were prepared by emulsifying method using 
liquid paraffin light and heavy in ratio of 50:50 as a 
dispersing medium and glutaraldehyde used as a cross-
linking agent. Thiolated chitosan dispersion (1.5% w/v) was 
prepared by mixing of thiolated chitosan in glacial acetic acid 
(4%w/v) with Tween 80 (0.5% w/w). Drug was dissolved in 
chitosan solution. The prepared, 10 ml of thiolated chitosan 
solution with drug was added dropwise in a beaker 
containing 100 ml of liquid paraffin light and heavy in ratio 
of 50:50 containing Span 80 (1.0% w/v). The system was 
kept under stirring at 3000-4000 rpm using two blade 
mechanical stirrers. 1.5 ml of glutaraldehyde saturated 
toluene was added to above solution after 30 min of stirring. 
Stirring was continued for 4 hr at 40ᵒC at 4000 rpm. The 
microspheres were separated from dispersion medium by 
centrifugation and washed two times with petroleum ether 
to remove liquid paraffin and then washed three times with 
acetone. Dispersion was poured in petridish to remove 
acetone. After complete evaporation of acetone, dried drug 
loaded microsphere were collected and stored in tight 
container for further evaluation. The compositions of 
formulation were given in table 1. 
Table 1 Formulations of the mucoadhesive microspheres  
F. Code 
Thiolated chitosan 
(%w/v) 
Tween-
80 (%) 
Span-80 
(%) 
F1 0.5 0.5 0.5 
F2 1.5 0.5 0.5 
F3 2.0 0.5 0.5 
F4 1.5 1.0 0.5 
F5 1.5 1.5 0.5 
F6 1.5 2.0 0.5 
Analytical method development 
Determination of absorption maxima  
A solution of containing the concentration 10 μg/ml was 
prepared in 0.1N HCl. UV spectrum was taken using Double 
beam UV/VIS spectrophotometer (Labindia-3000+). The 
solution was scanned in the range of 200-400nm.  
Preparation calibration curve  
Accurately weighed 10 mg of drug was dissolved in 10 ml of 
0.1N HCl solution in 10 ml of volumetric flask. The resulted 
solution 1000µg/ml and from this solution 1 ml pipette out 
and transfer into 10 ml volumetric flask and volume make up 
with 0.1N HCl solution. Prepare suitable dilution to make it 
to a concentration range of 5-25 μg/ml. The spectrum of this 
solution was run in 200-400 nm range in U.V. 
spectrophotometer (Labindia-3000+). Linearity of standard 
curve was assessed from the square of correlation coefficient 
(r2) which determined by least-square linear regression 
analysis. 
Evaluation of microspheres 
Measurement of mean particle size 
Average particles size of prepared microsphere was 
determined using particle size analyser (Malvern particle 
size analyser). The microsphere formulation was diluted 
with deionized water (1:9 v/v) and analysed for average size. 
Determination of drug content 
The amount of drug entrapped in the microspheres was 
determined using a UV spectrophotometer. The weighed 
amount of the microspheres was incubated with 0.1 N HCl, 
pH 1.2, for 48 h. It was centrifuged at 10,000 g for 30 min and 
the supernatant was diluted 10 times before analysis into the 
UV spectrophotometer system at λmax 292nm.  
Mucoadhesion measurement study 
Mucoadhesiveness of prepared microsphere was determined 
by taking a 5-6 cm length of piece obtained from freshly cut 
pig intestine which was procured from a local abattoir within 
1 h after sacrificed of animal. It was washed with isotonic 
saline solution. The pig intestine piece was attached to a 
polyethylene plate and placed 10 mg of microspheres on the 
mucosal surface. Plate was positioned at 40° angle relative to 
the horizontal plane. The time required for shedding all the 
microspheres from mucosal surface was noted. 
In Vitro drug release from microspheres  
The drug release was performed in 0.1 N HCl (1.2 pH) for 
drug loaded thiolated chitosan microsphere. The drug 
release was performed in 0.1 N HCl (1.2 pH) for prepared 
microsphere using dialysis bag technique. In this study 
suspension of microsphere equivalent to 20 mg of drug was 
taken in dialysis tubing (MWCO, 15KDa, himedia) and placed 
in a beaker containing 50ml of 0.1 N HCl (1.2 pH). The 
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dialysis bag retains microsphere and allows passing of free 
drug into the dissolution media. Temperature was 
maintained at 37±10C throughout the study. The samples 
were withdrawn after specified time intervals that are 0.5, 1, 
2, 3, 4, 8, 10 and 12hrs and replaced with the same volume of 
fresh 0.1 N HCl and analyzed for drug concentration by using 
UV spectrophotometer a λmax 292nm. 
Drug release kinetic data analysis 
A number of kinetic models have been planned to explain the 
release characteristics of a drug from matrix. The next three 
equations are usually used, because of their simplicity and 
applicability. Equation 1, the zero-order model equation 
(Plotted as cumulative percentage of drug released vs time); 
Equation 2, Higuchi’s square-root equation (Plotted as 
cumulative percentage of drug released vs square root of 
time); and Equation 3, the Korsemeyer-Peppas equation 
(Plotted as Log cumulative percentage of drug released vs 
Log time). To study the release kinetics of stavudine from the 
mucoadhesive microspheres the release data was fitted to 
these three equations11-13. 
Zero order equation 
When a graph of the cumulative percentage of the drug 
released from the matrix against time is plotted, zero order 
release is linear in such a plot, indicating that the release rate 
is independent of concentration. 
Qt = k0.t ……………………… (1) 
Where Qt is the percentage of drug released at time t and k0 is 
the releaserate constant; 
First order equation 
In (100-Qt) = In 100- kI.t ………………….. (2) 
 Where kI is the release rate constant; 
Higuchi’s equation 
Qt = kH.t1/2    ……………………….. (3) 
Where KH is the Higuchi release rate constant 
Korsemeyer-Peppas 
The curves plotted may have different slopes, and hence it 
becomes difficult to exactly pin-point which curve follows 
perfect zero order release kinetics. Therefore, to confirm the 
kinetics of drug release, data were also analyzed using 
Korsemeyer’s equation. 
Qt/Q∞ = kKP.tn 
Where Qt/ Q∞ is the fraction of drug released at time t, kKPa 
constant compromising the structural and geometric 
characteristics of the device and n is the release exponent. 
The slope of the linear curve gives the ‘n’ value. Peppas 
stated that the above equation could adequately describe the 
release of solutes from slabs, spheres, cylinders and discs, 
regardless of the release mechanism. The value of ‘n’ gives an 
indication of the release mechanism. When n = 1, the release 
rate is independent of time (typical zero order release / case 
II transport); n = 0.5 for Fickian release (diffusion/ case I 
transport); and when 0.5 < n < 1, anomalous (non-Fickian or 
coupled diffusion/ relaxation) are implicated. Lastly, when n 
> 1.0 super case II transport is apparent.  ‘n’ is the slope 
value of log Mt/M∞   versus log time curve14. 
RESULTS AND DISCUSSION 
λ max of lansoprazole was found to be 292 nm by using U.V. 
spectrophotometer (Labindia-3000+) in linearity range 5-
25µg/ml. Percentage yield of different formulation was 
determined by weighing the microspheres after drying.  The 
percentage yield of different formulation was in range of 
65.56– 85.45%. The Particle size of different formulations 
was in range of 195.45±0.69- 298.80±0.65nm. This is due to 
the mucoadhesion characteristics of chitosan that could 
facilitate the diffusion of part of entrapped drug to 
surrounding medium during preparation of lansoprazole 
microspheres Table 2 and Fig 1. 
Table 2 Results of percentage yield and particle size 
analysis of formulation F1-F6 
S. No. Formulation 
code 
Percentage 
Yield 
Particle size 
1. F1 68.98±0.25 298.80±0.65 
2. F2 65.56±0.12 256.21±0.25 
3. F3 85.45±0.25 195.45±0.69 
4. F4 76.54±0.14 269.98±1.25 
5. F5 73.25±0.36 278.85±0.96 
6. F6 72.15±0.14 292.12±0.45 
 
 
Figure 1 Graph of particle size analysis of optimized 
formulation F3 
The amount of drug entrapped in the microspheres was 
determined using a UV spectrophotometer. The weighed 
amount of the microspheres was incubated with 0.1 N HCl, 
pH 1.2, for 48 h. It was centrifuged at 10,000 g for 30 min and 
the supernatant was diluted 10 times before analysis into the 
UV spectrophotometer system at λmax 292nm table 3. The 
results of mucoadhesiveness of prepared microsphere were 
given in table 3.  
Table 3 Results of Drug content and % Mucoadhesion 
strength 
S. 
No. 
Formulation 
code 
% Mucoadhesion 
strength 
Drug 
Content  
1. F1 62.36±0.25 68.98±0.95 
2. F2 65.58±0.65 70.23±0.56 
3. F3 79.98±0.52 75.56±0.25 
4. F4 60.23±0.32 65.41±0.32 
5. F5 58.89±0.14 68.41±0.47 
6. F6 63.23±0.48 62.12±0.85 
 
The drug release rate from mucoadhesive microspheres was 
passed out using the USP type II (Electro Lab.) dissolution 
paddle instrument. A weighed amount of mucoadhesive 
microspheres equivalent to 20 mg drug were dispersed in 
900 ml of 0.1 N HCI (pH=1.2) maintained at 37 ± 0.5°C and 
stirred at 55rpm. The release study of optimized formulation 
F-3 was given in table 4. The kinetics of drug release from 
the microspheres was studied by mathematical modeling the 
drug release to zero order, first order kinetics Table 4 and 
Fig.5 & 6. 
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Table 4 Release study of formulation F-3 
Time (h) 
Square 
Root of 
Time(h)1/2 Log Time 
Cumulative*
% Drug 
Release 
Log 
Cumulative 
% Drug 
Release 
Cumulative %  
Drug 
Remaining 
Log 
Cumulative % 
Drug 
Remaining 
0.5 0.707 -0.301 18.89 1.276 81.11±0.45 1.909 
1 1.000 0.000 29.98 1.477 70.02±0.25 1.845 
2 1.414 0.301 36.65 1.564 63.35±0.32 1.802 
3 1.732 0.477 45.58 1.659 54.42±0.56 1.736 
4 2.000 0.602 65.56 1.817 34.44±0.25 1.537 
8 2.828 0.903 73.32 1.865 26.68±0.32 1.426 
10 3.162 1.000 80.24 1.904 19.76±0.45 1.296 
12 3.464 1.079 88.89 1.949 11.11±0.25 1.046 
 
The In vitro drug release data of the optimized formulation 
was subjected to goodness of fit test by linear regression 
analysis according to zero order and first order kinetic 
models in order to determine the mechanism of drug 
release. When the regression coefficient values of were 
compared, it was observed that ‘r’ values of First order was 
maximum i.e 0.964 hence indicating drug release from 
formulations was found to follow First order release kinetics 
table 5 and fig 2 &3.  
Table 5 Comparative study of regression coefficient for 
selection of optimize batch 
                     Zero order First order 
r2  R² = 0.906 R² = 0.964 
 
 
Figure 2 Zero order release Kinetics 
 
Figure 3 First order release kinetics  
CONCLUSION 
From the above experimental results, it can be concluded 
that oral controlled release of lansoprazole from microshere 
can be achieved by emulsifying method using thiolated 
chitosan as polymer and glutaraldehyde used as a cross-
linking agent. The IR spectra’s revealed that, there was no 
interaction between polymer and drug. The entire polymer 
used was compatible with the drug. Prepared microspheres 
exhibited First order release kinetics. From the study, it is 
evident that a promising controlled release microparticulate 
drug delivery of Lansoprazole can be developed. Further, in-
vivo investigation is required to establish efficacy of these 
formulations.  
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